Suchen
Baxter International Inc
BAXZur Watchlist hinzufügen
17.530USD
-0.460-2.56%
Handelsschluss 05/11, 16:00（ET）Kurse um 15 Minuten verzögert
9.05BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Baxter International Inc Unternehmen
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Baxter International Inc Informationen
BörsenkürzelBAX
Name des UnternehmensBaxter International Inc
IPO-datumJun 20, 2097
CEOHider (Andrew P)
Anzahl der mitarbeiter38000
WertpapierartOrdinary Share
GeschäftsjahresendeJun 20
AddresseOne Baxter Parkway
StadtDEERFIELD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl60015
Telefon12249482000
Websitehttps://www.baxter.com/
BörsenkürzelBAX
IPO-datumJun 20, 2097
CEOHider (Andrew P)
Führungskräfte von Baxter International Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
16.05K
-42.89%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.82K
+1.52%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
8.08K
+1.40%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Infusion Therapies and Technologies
4.10B
36.47%
Care and Connectivity Solutions
1.91B
17.00%
Injectables and Anesthesia
1.35B
12.02%
Advanced Surgery
1.20B
10.65%
Front Line Care
1.16B
10.32%
Andere
1.52B
13.54%
Nach RegionUSD
Name
Umsatz
Anteil
United States
6.12B
54.45%
International
5.12B
45.55%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Infusion Therapies and Technologies
4.10B
36.47%
Care and Connectivity Solutions
1.91B
17.00%
Injectables and Anesthesia
1.35B
12.02%
Advanced Surgery
1.20B
10.65%
Front Line Care
1.16B
10.32%
Andere
1.52B
13.54%
Aktionärsstatistik
Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Pzena Investment Management, LLC
12.49%
Dodge & Cox
11.04%
Vanguard Capital Management, LLC
6.49%
BlackRock Institutional Trust Company, N.A.
6.30%
BlackRock Financial Management, Inc.
5.88%
Andere
57.80%
Aktionäre
Aktionäre
Anteil
Pzena Investment Management, LLC
12.49%
Dodge & Cox
11.04%
Vanguard Capital Management, LLC
6.49%
BlackRock Institutional Trust Company, N.A.
6.30%
BlackRock Financial Management, Inc.
5.88%
Andere
57.80%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
50.99%
Investment Advisor
47.08%
Research Firm
2.40%
Hedge Fund
2.12%
Insurance Company
1.43%
Pension Fund
1.30%
Sovereign Wealth Fund
1.22%
Bank and Trust
0.83%
Private Equity
0.40%
Institutionelle Beteiligung
Aktualisiert: Sun, Apr 5
Aktualisiert: Sun, Apr 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
1767
557.84M
108.01%
-45.35M
2025Q4
1743
527.76M
108.76%
+72.60K
2025Q3
1826
527.84M
110.04%
+1.85M
2025Q2
1880
509.50M
105.73%
+4.72M
2025Q1
1916
504.93M
105.92%
-38.38M
2024Q4
1965
494.73M
105.04%
+14.02M
2024Q3
1980
482.92M
103.29%
+12.67M
2024Q2
2019
470.33M
102.19%
-1.85M
2024Q1
2069
469.00M
102.47%
-52.95M
2023Q4
2111
469.21M
101.33%
+9.34M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Pzena Investment Management, LLC
70.05M
13.57%
+12.66M
+22.06%
Dec 31, 2025
Dodge & Cox
57.00M
11.04%
-396.40K
-0.69%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
32.56M
6.31%
+1.24M
+3.96%
Dec 31, 2025
BlackRock Financial Management, Inc.
30.37M
5.88%
+5.68M
+23.02%
Dec 31, 2025
Fidelity Management & Research Company LLC
29.38M
5.69%
+17.44M
+146.19%
Dec 31, 2025
State Street Investment Management (US)
22.54M
4.37%
+542.01K
+2.46%
Dec 31, 2025
Greenhaven Associates, Inc.
10.69M
2.07%
+4.40M
+70.05%
Dec 31, 2025
Geode Capital Management, L.L.C.
13.51M
2.62%
+972.89K
+7.76%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Large Cap Value Active ETF
2.23%
First Trust Indxx Medical Devices ETF
1.69%
Invesco Raymond James SB-1 Equity ETF
1.5%
State Street SPDR S&P Health Care Equipment ETF
1.37%
Invesco S&P 500 Equal Weight Health Care ETF
1.26%
Franklin US Dividend Booster Index ETF
1.26%
iShares U.S. Medical Devices ETF
1.13%
Invesco Zacks Multi-Asset Income ETF
0.8%
Humankind US Stock ETF
0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.57%
Mehr Anzeigen
iShares Large Cap Value Active ETF
Anteil2.23%
First Trust Indxx Medical Devices ETF
Anteil1.69%
Invesco Raymond James SB-1 Equity ETF
Anteil1.5%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.37%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.26%
Franklin US Dividend Booster Index ETF
Anteil1.26%
iShares U.S. Medical Devices ETF
Anteil1.13%
Invesco Zacks Multi-Asset Income ETF
Anteil0.8%
Humankind US Stock ETF
Anteil0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Anteil0.57%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.28B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Apr 29, 2026
BAX.NB Interim Cash Dividend of gross USD 0.01 paid on Jul 01, 2026 going ex on May 29, 2026
May 29, 2026
Jul 01, 2026
May 29, 2026
Feb 12, 2026
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026
Feb 27, 2026
Apr 01, 2026
Feb 27, 2026
Feb 12, 2026
BAX.NB Interim Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026 with reinvestment option
Feb 27, 2026
Apr 01, 2026
Feb 27, 2026
Nov 11, 2025
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Jan 02, 2026 going ex on Nov 28, 2025 with reinvestment option
Nov 28, 2025
Jan 02, 2026
Nov 28, 2025
Jul 14, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 01, 2025 going ex on Aug 29, 2025 with reinvestment option
Aug 29, 2025
Oct 01, 2025
Aug 29, 2025
May 06, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 01, 2025 going ex on May 30, 2025 with reinvestment option
May 30, 2025
Jul 01, 2025
May 30, 2025
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Mehr Anzeigen
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
